Blog
RSS FeedPosted by Michael Wonder on 05 Feb 2017
Riverina mother to tackle government over PBS' refusal to list cystic fibrosis drug
5 February 2017 - A government decision to keep a revolutionary drug out of the hands of desperate parents has ...
Posted by Michael Wonder on 04 Feb 2017
Drug game-changer for thousands suffering from cystic fibrosis headed for the PBS
5 February 2017 - Australia's youngest cystic fibrosis sufferers will this week get a massive reprieve when the government lists ...
Posted by Michael Wonder on 04 Feb 2017
Most important breast cancer drug in two decades will not get NHS funding
3 February 2017 - A new drug described as one of the "most important" advances in treating breast cancer ...
Posted by Michael Wonder on 04 Feb 2017
Healthcare ‘bravery’ needed, says HBF boss Bransby
4 February 2017 - The Turnbull government needs to be “brave” and tackle “hideous” healthcare costs, health insurance boss Rob ...
Posted by Michael Wonder on 03 Feb 2017
Breast cancer drug costs too high in relation to benefits for routine NHS funding
3 February 2017 - NICE does not recommend breast cancer drug palbociclib (Ibrance, Pfizer) because its cost is too high in ...
Posted by Michael Wonder on 03 Feb 2017
Influenza vaccine in pharmacies
3 February 2017 - PHARMAC proposes changes to the Pharmaceutical Schedule to fund the provision of influenza vaccine (flu vaccine) ...
Posted by Michael Wonder on 03 Feb 2017
Agenda for 8 February 2017 TC meeting
3 February 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 02 Feb 2017
Potential drug price hike could be a hard pill to swallow
3 February 2017 - New Zealand may have to swallow higher drug prices if it wants a trade deal with the ...
Posted by Michael Wonder on 02 Feb 2017
Mind the gap - an analysis of cancer medicines in New Zealand and Australia
2 February 2017 - When it comes making a difference in people’s lives, it’s not about how many medicines you ...
Posted by Michael Wonder on 02 Feb 2017
Proposal to list orthopaedic hip and knee implants, cement and associated products on the Pharmaceutical Schedule
2 February 2017 - PHARMAC is seeking feedback on a proposal to list further ranges of orthopaedic implants and associated ...
Posted by Michael Wonder on 02 Feb 2017
Quality over quantity more important in health outcomes
2 February 2017 - When it comes to making a difference in people’s lives, it’s not about how many medicines ...
Posted by Michael Wonder on 02 Feb 2017
AusBiotech consults biotech CEOs on industry advocacy
2 February 2017 - AusBiotech has launched its annual consultation of membership issues, calling for leaders of biotechnology companies to ...
Posted by Michael Wonder on 01 Feb 2017
Senate inquiry on prostheses pricing urged to consider implications
31 January 2017 - AusBiotech has made a submission to the Senate’s Community Affairs References Committee Inquiry into the ‘Price ...
Posted by Michael Wonder on 01 Feb 2017
Advanced ovarian cancer treatment placed on the PBS, a move praised by doctors and patients
1 January 2017 - Women with advanced ovarian cancer can now pay significantly less for a groundbreaking drug, in a ...
Posted by Michael Wonder on 01 Feb 2017
Challenges in the assessment of medical devices: the MedtecHTA project
31 January 2017 - Assessing medical devices raises challenges which require us to reflect on whether current methods are adequate. ...